Results 61 to 70 of about 14,282 (89)

Targeting STAT5A via CRISPR/Cas9 restores TKI sensitivity in resistant chronic myeloid leukemia cells. [PDF]

Med Oncol
Çelik B, Kiraz Y, Şahin Y, Tezcanlı Kaymaz B.   +3 more
europepmc   +1 more source

Exportin 1 as a Therapeutic Target to Overcome Drug Resistance in Lung Cancer. [PDF]

Cells
Di Marco MV, Gasparetto A, Chiarle R, Voena C.   +3 more
europepmc   +1 more source

Targeting "undruggable" cancer proteins: pharmacological challenges and emerging strategies. [PDF]

Transl Cancer Res
Coelho-Silva JL, Parducci NS, Carvalho MFL, Vahedian V, Lima K, de Almeida BO, Machado-Neto JA.   +6 more
europepmc   +1 more source

Advances in Targeting BCR-ABL^T315I Mutation with Imatinib Derivatives and Hybrid Anti-Leukemic Molecules. [PDF]

Molecules
Tuzikiewicz A, Wawrzyniak W, Kutner A, Żołek T.   +3 more
europepmc   +1 more source

AID and TET2 cooperate to demethylate Irf4 for plasma cell fate in germinal center B cells. [PDF]

J Exp Med
He M, D'Aulerio R, Pinho LG, Doukoumopoulos E, Yong T, Vieira RC, Oliveira MMS, Eiben L, Termote M, Galvani RG, Sedimbi S, Seitz C, Kuznetsov NV, Zuriaga MA, Kitamura D, Fuster JJ, Cotta-de-Almeida V, Ström L, Dosenovic P, Degn SE, Westerberg LS.   +20 more
europepmc   +1 more source

BCR::ABL1-Induced Enhancer Reprogramming Uncovers Hypersensitivity of Ph+B-ALL Cells to Enhancer-Targeting Drugs. [PDF]

Adv Sci (Weinh)
Ng HL, Glaser TL, Zhu J, Robinson ME, Cosgun KN, Malysheva V, Deniz O, Crump NT, Helian K, Innes AJ, Burt R, Sun L, John G, Zhou H, Kaneshige A, Bai L, Wang S, Spivakov M, Müschen M, Feldhahn N.   +19 more
europepmc   +1 more source

A Rare Case of De Novo Acute Myeloid Leukemia, Featuring a <i>KMT2A</i> (<i>MLL</i>) Amplification. [PDF]

Diagnostics (Basel)
Hassan F, Chen J, Westphal C, Tirado CA.
europepmc   +1 more source

Extramedullary Involvement in T/Myeloid Mixed Phenotype Acute Leukemia With BCR::ABL1 Fusion in a Hispanic Female Patient: A Case Report. [PDF]

Cureus
Santiago-Negron CL, Cordero Hernández JM, Marrero-León WD, Rivera Rolón MD.   +3 more
europepmc   +1 more source

Epstein-Barr virus (EBV) infection causes human germinal center B cell-derived lymphomas in the absence of EBNA2 expression. [PDF]

Proc Natl Acad Sci U S A
Wang C, Bristol JA, Nelson SE, Chen T, Hendrickson C, Baiu DC, Riel M, Hayes M, Ranheim EA, Gumperz JE, Johannsen EC, Kenney SC.   +11 more
europepmc   +1 more source